Berkeley Lovelace Jr. is a health and medical news reporter for NBC News.
The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16 months. Zepbound is the latest entrant into the field of powerful new drugs that already includes Novo Nordisk’s Ozempic and Wegovy and Lilly’s Mounjaro. The FDA approved the drug for adults with obesity or who are overweight with at least one weight-related condition.
“When I’m talking to a patient, I’m going to discuss both of them,” he said. The new drug, like others in its class, comes with side effects including gastrointestinal problems. Dr. Daniela Hurtado Andrade, an endocrinologist at the Mayo Clinic, said that while gastrointestinal issues are very common with GLP-1 medications, most of the side effects will not affect a person’s quality of life.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
US FDA approves Lilly weight-loss drug, will compete with Novo's WegovyUS FDA approves Lilly weight-loss drug, will compete with Novo's Wegovy
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight loss under a new nameIt's the latest diabetes drug approved for weight loss.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossSetting—and sticking to—a holiday budget could help you avoid finical hardship down the road.
Weiterlesen »
FDA approves new version of Eli Lilly diabetes drug for weight lossThere's a unique therapy option for Hoosiers with disabilities or who are battling a mental health challenge.
Weiterlesen »
FDA approves new version of diabetes drug Mounjaro for weight lossEven though multiple suspects have been captured on camera, so far police haven't been able to catch the crooks.
Weiterlesen »
FDA approves new diabetes drug Mounjaro for weight lossA new diabetes drug has been approved by the US Food and Drug Administration for use as a weight-loss drug.
Weiterlesen »